ATE180986T1 - Verfahren zur reinigung von hmg-coa reductase- inhibitoren - Google Patents

Verfahren zur reinigung von hmg-coa reductase- inhibitoren

Info

Publication number
ATE180986T1
ATE180986T1 AT92908427T AT92908427T ATE180986T1 AT E180986 T1 ATE180986 T1 AT E180986T1 AT 92908427 T AT92908427 T AT 92908427T AT 92908427 T AT92908427 T AT 92908427T AT E180986 T1 ATE180986 T1 AT E180986T1
Authority
AT
Austria
Prior art keywords
coa reductase
reductase inhibitors
hmg
purifying
purifying hmg
Prior art date
Application number
AT92908427T
Other languages
English (en)
Inventor
Peter N Haytko
Arthur S Wildman Jr
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24683910&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE180986(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE180986T1 publication Critical patent/ATE180986T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32—Bonded phase chromatography
    • B01D15/322—Normal bonded phase
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32—Bonded phase chromatography
    • B01D15/325—Reversed phase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
AT92908427T 1991-03-13 1992-03-09 Verfahren zur reinigung von hmg-coa reductase- inhibitoren ATE180986T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/668,831 US5202029A (en) 1991-03-13 1991-03-13 Process for purification of hmg-coa reductase inhibitors

Publications (1)

Publication Number Publication Date
ATE180986T1 true ATE180986T1 (de) 1999-06-15

Family

ID=24683910

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92908427T ATE180986T1 (de) 1991-03-13 1992-03-09 Verfahren zur reinigung von hmg-coa reductase- inhibitoren

Country Status (9)

Country Link
US (1) US5202029A (de)
EP (1) EP0578723B1 (de)
JP (1) JPH06506210A (de)
AT (1) ATE180986T1 (de)
CA (1) CA2104232A1 (de)
DE (1) DE69229393D1 (de)
ES (1) ES2132121T3 (de)
GR (1) GR3030446T3 (de)
WO (1) WO1992016276A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308479A (en) * 1989-05-26 1994-05-03 Isamu Iwai Sewage disposal apparatus employing circulating filter media
DE4414537A1 (de) * 1994-04-26 1995-11-02 Klinge Co Chem Pharm Fab Kombinationspräparate mit einem Gehalt an einem p-Oxybenzoesäurederivat und einem HMG-CoA-Reduktase-Hemmer
SI9800046A (sl) 1998-02-18 1999-08-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze visoke čistosti
SI20072A (sl) * 1998-09-18 2000-04-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze
US7141602B2 (en) * 1998-09-18 2006-11-28 Lek Pharmaceuticals D.D. Process for obtaining HMG-CoA reductase inhibitors of high purity
CA2388182A1 (en) 1999-10-27 2001-05-03 Merck & Co., Inc. Lactonization process
MXPA02005283A (es) 1999-11-30 2003-10-06 Biogal Gyogyszergyar Proceso para recuperar compuestos estatina de un caldo de fermentacion.
IL150187A0 (en) * 1999-12-14 2002-12-01 Biogal Pharmaceutical Co Ltd Novel forms of pravastatin sodium
HUP0300073A3 (en) 2000-02-24 2004-10-28 Teva Gyogyszergyar Zartkoeruee Method of purifying a fermentation broth
EP1265884A4 (de) 2000-03-03 2003-05-21 Plus Chemical S A Ein verfahren zur reinigung von lovastatin und simvastatin mit verringertem gehalt an dimeren verunreinigungen
US20020164644A1 (en) * 2000-04-05 2002-11-07 Ikuro Maruyama Adsorbents for high mobility group proteins and column for purifying body fluid
US6936731B2 (en) * 2000-10-05 2005-08-30 TEVA Gyógyszergyár Részvénytársaság Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same
US20050215636A1 (en) * 2000-10-05 2005-09-29 Vilmos Keri Pravastatin sodium substantially free of pravastatin lactone and EPI-pravastatin, and compositions containing same
EP1330245A4 (de) * 2000-10-05 2004-10-20 Biogal Gyogyszergyar Pravastatin-natrium, das im wesentlichen frei von pravastatin-lacton und epipravastatin ist, und dieses enthaltende zusammensetzungen
JP3236282B1 (ja) * 2000-10-16 2001-12-10 三共株式会社 プラバスタチンを精製する方法
US7368468B2 (en) * 2003-06-18 2008-05-06 Teva Pharmaceutical Industries Ltd. Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them
US7414140B2 (en) 2003-06-18 2008-08-19 Teva Pharmaceutical Industries Ltd. Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them
EP1601658A1 (de) * 2003-11-24 2005-12-07 Teva Pharmaceutical Industries Limited Kristalline ammoniumsalze von rosuvastatin
DE602004017461D1 (de) 2003-11-24 2008-12-11 Teva Gyogyszergyar Zartkoeruen Verfahren zur reinigung von pravastatin
US7851624B2 (en) * 2003-12-24 2010-12-14 Teva Pharamaceutical Industries Ltd. Triol form of rosuvastatin and synthesis of rosuvastatin
US20070179166A1 (en) * 2003-12-24 2007-08-02 Valerie Niddam-Hildesheim Process for preparation of statins with high syn to anti ratio
ES2239533B1 (es) * 2004-03-01 2006-12-16 Ercros Industrial, S.A. Procedimiento para la obtencion de compactina.
WO2006035295A1 (en) * 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Process for the purification of lovastatin
CA2591439C (en) * 2005-02-22 2013-03-26 Teva Pharmaceutical Industries Ltd. Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof
WO2009078033A2 (en) * 2007-12-18 2009-06-25 Themis Medicare Limited Isolation and recovery of simvastatin in lactone form or in the form of an acid salt from the harvested fermentation broth
SG175085A1 (en) * 2009-04-08 2011-11-28 Nanyang Polytechnic A plant extract comprising statins and preparation techniques and uses thereof
CN102043030A (zh) * 2009-10-22 2011-05-04 北京万全阳光医学技术有限公司 一种用高效液相色谱法测定烟酸辛伐他汀缓释片有关物质的方法
US8801924B2 (en) * 2010-07-07 2014-08-12 Ironstone Separations, Inc. Chromatography methods
EP2597092A1 (de) 2011-11-24 2013-05-29 Sterling Biotech Limited Verfahren zum Reinigen von Lovastatin
CN112657231B (zh) * 2020-12-24 2022-06-10 西安蓝晓科技新材料股份有限公司 一种三七总皂苷的提纯工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
JPS58140024A (ja) * 1982-02-15 1983-08-19 Eisai Co Ltd セクレチンの精製方法
US4833258A (en) * 1987-02-17 1989-05-23 Merck & Co., Inc. Intermediates useful in the preparation of HMG-COA reductase inhibitors
US4719229A (en) * 1987-05-13 1988-01-12 Merck & Co., Inc. Antihypercholesterolemic agents
US4778600A (en) * 1987-06-17 1988-10-18 Dow Corning Corporation Liquid chromatography dual zone packing materials
US4997755A (en) * 1988-04-15 1991-03-05 Merck & Co., Inc. HMG-CoA reductase inhibitors produced by Nocardia sp. (MA 6455)
US5099035A (en) * 1989-02-27 1992-03-24 E. R. Squibb & Sons, Inc. Mevinic acid derivatives useful as antihypercholesterolemic agents and method for preparing same
US5102911A (en) * 1989-06-09 1992-04-07 Merck & Co, Inc. 4-Substituted HMG-CoA reductase inhibitors
US4997849A (en) * 1989-06-23 1991-03-05 Merck & Co., Inc. Microbial transformation of simvastatin
US4965200A (en) * 1989-06-23 1990-10-23 Merck & Co., Inc. Process for the preparation of 3-keto, 5-hydroxy simvastatin analogs
US5089523A (en) * 1990-05-11 1992-02-18 E. R. Squibb & Sons, Inc. Fluorinated derivatives of mevinic acids

Also Published As

Publication number Publication date
GR3030446T3 (en) 1999-09-30
EP0578723A1 (de) 1994-01-19
CA2104232A1 (en) 1992-09-14
DE69229393D1 (de) 1999-07-15
EP0578723B1 (de) 1999-06-09
ES2132121T3 (es) 1999-08-16
WO1992016276A1 (en) 1992-10-01
JPH06506210A (ja) 1994-07-14
US5202029A (en) 1993-04-13
EP0578723A4 (en) 1994-06-22

Similar Documents

Publication Publication Date Title
ATE180986T1 (de) Verfahren zur reinigung von hmg-coa reductase- inhibitoren
DE69529936T2 (de) Verfahren zur Quantifizierung von spezifischen Verbindungen
DE69321843T2 (de) Verfahren zur entsorgung von stadtmüll
DE69406059D1 (de) Verfahren zur Gasphasenpolymerisation von Olefin
DE69310324D1 (de) Verfahren zur Entschwefelung von Kohlenwasserstoffen
DE69508733T2 (de) Verfahren zur Carboxylierung eines Alkohols
DE69400257D1 (de) Verfahren zur Reinigung von Pentafluorethan
DE69202962T2 (de) Verfahren zur Glycidylierung von Alkoholen.
FI962086A (fi) Faasierotuslaite
DE69314365D1 (de) Verfahren zur Monohydroxylierung von Phenolverbindungen
DE69633579D1 (de) Verfahren zur Rückgewinnung von Quecksilber
DE69433634D1 (de) Verfahren zur Umsetzung von Kohlenwasserstoffen
EA199900221A1 (ru) Синтез бисиндолилмалеимидов
DE69415837T2 (de) Verfahren zur Verminderung des freien Aldehydgehaltes von N-Alkylolamidmonomeren
DE69411333T2 (de) Verfahren zur Rückgewinnung von verbrauchten Metallätzlösungen
DE69412559T2 (de) Verfahren zur Vergasung von organischen Materien
ATE200079T1 (de) Verfahren zur herstellung von hiv-proteasehemmern
DE69212731D1 (de) Verfahren zur elektro-osmotischen Entwässerung von Schlamm
DE69406205D1 (de) Verfahren zur Isomerisierung von Cis-Alkenylverbindungen
DK133793A (da) Fremgangsmåde til dehydrogenering af carbonhydrider
DE59405678D1 (de) Verfahren zur Reinigung von alkalischem Prozesskondensat-Abwasser
DE59400815D1 (de) Verfahren zur umweltfreundlichen verwertung von sauren abwässern
DE59604072D1 (de) Verfahren zur Entsorgung von organischen Verbindungen
ATA109793A (de) Verfahren zur prophylaxe der hypokalzämischen gebärlähmung und der atypischen gebärparese des rindes
DE69205341T2 (de) Verfahren zur Reinigung von Diaminodiphenylverbindungen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee